🚨 BREAKING: The FDA has approved teplizumab, an immune therapy drug shown to delay the onset of type 1 diabetes.
Read our full coverage here.
https://t.co/Lqi960npVu
Fact #1: Nearly 36,000 lives were lost to Type 1 diabetes in 2022 globally without ever receiving a diagnosis (Source: T1D Index).
Fact #2: Awareness saves lives.
Share your diagnosis story to help others #SeeTheSigns: https://t.co/BemV8HYQDp
JDRF, in collaboration with key partners and experts around the world, are excited to announce the launch of the Type 1 Diabetes Index (T1D Index). (1/4)
I am blessed and grateful to announce that I have decided to continue my academic and athletic careers at Albion College. I would like to thank God, my family, coaches, and teammates for helping me along the way.#GoBrits@BritonsBaseball@SalineHSBasebal@LegacyMI_BAS@Oaksman11
The FDA has cleared the much-anticipated feature that will allow you to bolus from your compatible smartphone using the t:connect mobile app. More details below. #freedom2bolus#T1D
RX ONLY. For ages 6+. Indications and warnings: https://t.co/tFtdQjhSxQ.
https://t.co/ZrpR43vYr4
No person living with diabetes should go without insulin. If you or someone you love is struggling to access insulin, https://t.co/EMEKw1PLwd can help.
Glucagon works by targeting the liver. But when you've had a lot of alcohol, your liver is busy dealing with that, and glucagon may not work. https://t.co/TZNoOrRdXy